Chiron Will Not Supply Begrivac Flu Vaccine This Season
This article was originally published in The Pink Sheet Daily
Executive Summary
Chiron will not deliver its influenza vaccine Begrivac to non-U.S. markets in the 2005-2006 flu season, the firm said July 20
You may also be interested in...
Chiron Deal Offers Novartis Entry Into Vaccine Business
Novartis seeks to acquire remaining 57.8% of Chiron it does not already own with an all-cash bid of $4.5 bil.
Chiron Deal Offers Novartis Entry Into Vaccine Business
Novartis seeks to acquire remaining 57.8% of Chiron it does not already own with an all-cash bid of $4.5 bil.
Chiron Response To FDA "483" Report For Fluvirin Plant Expected In Early August
FDA issued its observations following a nine-day inspection of the company's Liverpool, U.K. manufacturing facility in mid-July.